ASE Technology

US · ASX #252 by market cap Listed 2000

31.63 +1.91 +6.43%

Periodic snapshot; not a real-time feed. · 2026-11-06 20:02

Official SEC filings

Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-07 05:43 UTC.

Form	Filed	Original document
6-K	2026-10-29	Read on SEC.gov
6-K	2026-10-29	Read on SEC.gov
6-K	2026-10-13	Read on SEC.gov
6-K	2026-09-09	Read on SEC.gov
6-K	2026-08-10	Read on SEC.gov
6-K	2026-08-03	Read on SEC.gov
6-K	2026-08-03	Read on SEC.gov
6-K	2026-07-30	Read on SEC.gov

✦ Quant Financial Health how this is computed

Weak

Altman Z-Score is 1.26, below the 1.8 "distress zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Packaging is the largest reported line at 50.04% of revenue, across 4 reported segments.
Electronic manufacturing services (EMS) follows at 38.09%, so the top line still matters most but isn’t the whole story.

Revenue annual, last 8 years

Latest year +8.39% YoY

Margins

Gross margin: 17.69%
Operating margin: 7.99%
Net margin: 6.20%

Key ratios & quality

Enterprise value: 224.78B
Altman Z-Score: 1.26

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	371.09B	413.18B	476.98B	570.00B	670.87B	581.91B	595.41B	645.39B
Gross profit	61.16B	64.31B	77.98B	110.37B	134.93B	91.76B	96.93B	114.19B
Selling & admin expenses	19.55B	22.39B	23.81B	27.19B	30.38B	25.93B	28.94B	30.59B
Research & development	14.96B	18.40B	19.30B	21.05B	24.37B	25.50B	28.83B	32.85B
Operating profit	27.44B	24.11B	36.56B	63.96B	81.54B	41.88B	40.41B	51.53B
Pretax profit	31.94B	23.28B	35.77B	80.19B	81.76B	42.61B	41.73B	51.30B
Tax	4.51B	5.01B	7.12B	17.94B	17.15B	5.30B	7.92B	10.11B
Net profit	27.42B	18.27B	28.65B	62.25B	64.62B	37.31B	33.82B	41.20B
Basic EPS	12	8	13	28	29	17	15	18
Diluted EPS	12.14	7.82	12.34	27.08	27.62	16.08	14.40	17.50

Line item	2025-06	2025-09	2025-12	2026-03	2026-06	2026-09
Revenue	150.75B	168.57B	177.92B	173.66B	191.06B	244.16B
Gross profit	25.69B	28.88B	34.74B	34.85B	40.15B	53.97B
Selling & admin expenses	7.49B	7.37B	8.08B	8.11B	8.79B	9.55B
Research & development	8.00B	8.31B	8.96B	9.21B	10.23B	11.27B
Operating profit	10.19B	13.20B	18.47B	17.61B	21.13B	33.14B
Pretax profit	9.26B	13.98B	18.26B	18.20B	25.70B	32.71B
Tax	1.58B	2.62B	3.89B	3.64B	4.17B	4.83B
Net profit	7.68B	11.36B	14.37B	14.56B	21.53B	27.88B
Basic EPS	3	5	7	6	10	12
Diluted EPS	3.40	4.82	6.48	6.16	9.22	11.68

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	201.56B	202.00B	224.09B	292.36B	300.37B	261.68B	275.29B	313.80B
Cash & ST investments	65.32B	65.02B	56.43B	79.15B	65.60B	71.97B	85.87B	101.98B
Inventory	46.69B	45.30B	62.06B	73.25B	92.83B	63.33B	61.18B	69.38B
Total assets	534.06B	557.22B	584.15B	673.27B	707.59B	667.39B	741.06B	889.50B
Total current liabilities	158.63B	154.30B	174.59B	217.25B	229.33B	225.97B	234.42B	248.48B
Short-term debt	54.04B	43.33B	41.32B	49.56B	45.55B	70.20B	54.86B	41.70B
Long-term debt	144.11B	172.24B	151.51B	159.53B	137.80B	101.85B	139.73B	214.08B
Total liabilities	315,034,005,000.00	344,421,394,000.00	352,415,528,000.00	405,094,839,000.00	394,313,457,000.00	352,642,080,000.00	398,789,156,000.00	520,870,658,000.00
Total equity	219.03B	212.80B	231.74B	268.17B	313.28B	314.75B	342.27B	368.63B
Retained earnings	20.40B	21.03B	30.08B	69.71B	91.56B	89.98B	96.64B	108.96B

Line item	2025-06	2025-09	2025-12	2026-03	2026-06	2026-09
Total current assets	254.00B	294.08B	313.80B	337.70B	360.40B	419.47B
Cash & ST investments	76.90B	83.41B	101.98B	113.95B	107.37B	107.94B
Inventory	57.06B	66.18B	69.38B	76.04B	86.27B	99.72B
Total assets	765.18B	842.64B	889.50B	957.53B	1.07T	1.24T
Total current liabilities	248.97B	259.55B	248.48B	294.50B	336.80B	362.88B
Short-term debt	53.30B	67.81B	41.70B	47.39B	71.85B	75.57B
Long-term debt	178.99B	218.95B	214.08B	201.14B	224.59B	318.83B
Total liabilities	450,240,000,000.00	503,091,000,000.00	520,870,658,000.00	576,383,490,000.00	652,137,000,000.00	790,863,000,000.00
Total equity	314.94B	339.55B	368.63B	381.14B	419.20B	453.92B
Retained earnings	--	--	108.96B	97.01B	--	--

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	51.07B	72.30B	75.06B	81.73B	111.00B	114.42B	90.79B	142.25B
Depreciation & amortization	42.69B	50.47B	51.26B	54.52B	55.45B	58.10B	59.82B	67.44B
Free cash flow	9.11B	13.79B	11.88B	8.80B	37.30B	59.83B	9.11B	-23.60B
Dividends paid	-10.61B	-10.62B	-8.52B	-18.08B	-29.99B	-37.84B	-22.46B	-23.03B
Stock buybacks / issuance	-71.30M	0	0	-5.53B	-205.61M	0	0	--
Ending cash balance	51.52B	60.13B	51.54B	76.07B	58.04B	67.28B	76.49B	92.47B

Line item	2025-06	2025-09	2025-12	2026-03	2026-06	2026-09
Operating cash flow	36.85B	14.63B	70.81B	36.39B	47.01B	50.46B
Depreciation & amortization	16.53B	16.99B	17.83B	18.65B	20.00B	22.26B
Free cash flow	-6.26B	-30.29B	29.33B	-9.97B	-32.84B	-75.39B
Dividends paid	--	-23.03B	11.00K	--	--	-28.96B
Stock buybacks / issuance	--	--	--	--	--	--
Ending cash balance	72.79B	75.14B	92.47B	87.81B	91.29B	88.42B

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	13.46	8.51	12.98	25.61	22.43	12.04	10.54	12.09
ROA %	5.84	3.13	4.73	9.57	8.91	5.16	4.60	4.91
ROIC %	8.81	4.85	7.03	14.02	13.44	8.26	7.30	7.90
5-year avg ROE %	14.03	12.43	12.41	14.77	16.60	16.31	16.72	16.54
EBIT margin %	9.56	6.65	8.22	14.56	12.78	8.39	8.14	9.11
FCF / sales %	2.46	3.34	2.49	1.54	5.56	10.28	1.53	--
Current ratio	1.27	1.31	1.28	1.35	1.31	1.16	1.17	1.26
Quick ratio	0.95	0.98	0.90	0.99	0.89	0.86	0.89	0.96
Debt / assets	37.10	39.62	33.88	32.03	26.86	26.85	27.18	29.64
LT debt / equity	71.56	88.96	72.47	65.50	49.05	37.02	45.79	64.87
Interest coverage	10.03	6.56	11.41	29.65	21.50	7.83	7.18	7.86
Revenue CAGR (3Y) %	9.42	14.55	17.98	15.38	17.53	6.85	1.46	-1.28
Net income CAGR (3Y) %	9.94	-7.17	5.73	31.89	53.33	9.55	-18.65	-13.35
FCF CAGR (3Y) %	-30.19	-17.85	-19.04	-1.14	39.31	71.40	1.13	--

Line item	2025-06	2025-09	2025-12	2026-03	2026-06	2026-09
ROE %	11.41	11.22	12.09	14.08	17.61	20.62
ROA %	4.70	4.52	4.91	5.38	6.55	7.31
ROIC %	7.91	7.32	7.90	8.99	11.06	11.85
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	8.02	8.20	9.11	10.06	11.89	13.28
FCF / sales %	--	--	--	--	--	--
Current ratio	1.02	1.13	1.26	1.15	1.07	1.16
Quick ratio	0.72	0.81	0.96	0.86	0.74	0.78
Debt / assets	30.36	34.03	29.64	26.73	27.67	31.68
LT debt / equity	60.93	69.06	64.87	59.49	57.70	75.40
Interest coverage	7.18	7.29	7.86	8.66	10.01	10.85
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

Revenue breakdown most recent period

Business

Packaging50.04%

Electronic manufacturing services (EMS)38.09%

Testing10.77%

Others1.10%

Quote time 2026-11-06 20:02:27 · For reference only, not investment advice and not tailored to your situation.